Cargando…
The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors
Hepatitis C virus (HCV) infects over 170 million people worldwide and is the leading cause of chronic liver diseases, including cirrhosis, liver failure, and liver cancer. Available antiviral therapies cause severe side effects and are effective only for a subset of patients, though treatment outcom...
Autores principales: | Romano, Keith P., Ali, Akbar, Aydin, Cihan, Soumana, Djade, Özen, Ayşegül, Deveau, Laura M., Silver, Casey, Cao, Hong, Newton, Alicia, Petropoulos, Christos J., Huang, Wei, Schiffer, Celia A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406087/ https://www.ncbi.nlm.nih.gov/pubmed/22910833 http://dx.doi.org/10.1371/journal.ppat.1002832 |
Ejemplares similares
-
Structural Analysis of Asunaprevir Resistance in HCV
NS3/4A Protease
por: Soumana, Djadé I., et al.
Publicado: (2014) -
Molecular Basis for Drug Resistance in HIV-1 Protease
por: Ali, Akbar, et al.
Publicado: (2010) -
Drug-resistant HIV-1 protease regains functional dynamics through cleavage site coevolution
por: Özer, Nevra, et al.
Publicado: (2015) -
Avoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors
por: Matthew, Ashley N., et al.
Publicado: (2020) -
Hepatitis C Viral NS3-4A Protease Activity Is Enhanced by the NS3
Helicase
por: Beran, Rudolf K. F., et al.
Publicado: (2008)